← FDA Drug Approvals (Drugs@FDA)
LORBRENA
NDA · New Drug Application · Sponsor: PFIZER · Approved 2018-11-02
Drug application
- FDA Application #
NDA210868- Application type
- New Drug Application
- Brand name
- LORBRENA
- Generic name
- LORLATINIB
- Active ingredients
- LORLATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PFIZER
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- First approval
- 2018-11-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown